Authors: Berrie, CP

Citation: Cp. Berrie, Phosphoinositide 3-kinase inhibition in cancer treatment, EXPERT OP I, 10(6), 2001, pp. 1085-1098

Authors: Zaru, R Berrie, CP Lurisci, C Corda, D Valitutti, S

Citation: R. Zaru et al., CD28 co-stimulates TCR/CD3-induced phosphoinositide turnover in human T lymphocytes, EUR J IMMUN, 31(8), 2001, pp. 2438-2447

Authors: Razzini, G Berrie, CP Vignati, S Broggini, M Mascetta, G Brancaccio, A Falasca, M

Citation: G. Razzini et al., Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines, FASEB J, 14(9), 2000, pp. 1179-1187

Authors: Berrie, CP Falasca, M

Citation: Cp. Berrie et M. Falasca, Patterns within protein/polyphosphoinositide interactions provide specifictargets for therapeutic intervention, FASEB J, 14(15), 2000, pp. 2618-2622

Authors: Snoek, GT Berrie, CP Geijtenbeek, TBH van der Helm, HA Cadee, JA Iurisci, C Corda, D Wirtz, KWA

Citation: Gt. Snoek et al., Overexpression of phosphatidylinositol transfer protein alpha in NIH3T3 cells activates a phospholipase A, J BIOL CHEM, 274(50), 1999, pp. 35393-35399

Authors: Berrie, CP Iurisci, C Corda, D

Citation: Cp. Berrie et al., Membrane transport and in vitro metabolism of the Ras cascade messenger, glycerophosphoinositol 4-phosphate, EUR J BIOCH, 266(2), 1999, pp. 413-419